Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This is a phase II trial in individuals who have been diagnosed with type 1 diabetes within
the previous 6 months. The study is evaluating whether stem cell transplantation is safe when
chemotherapy and immunotherapy are used in combination and if it has immune resetting effect
that may halt the immune attack to pancreas islets and thus preserve the body's own insulin
production.